The story has been updated with executive comment and stock price change Healthcare insurance giant Centene Corporation (NYSE ...

Analysts have given Centene a total of 16 ratings, with the consensus rating being Neutral. The average one-year price target is $49.62, indicating a potential 68.66% upside.

Centene on Friday posted a surprise quarterly loss, in yet another disappointment for investors in the sector that has suffered a series of setbacks due to rising costs in government-backed insurance ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the ...

Centene is responding by repricing plans for 2026 and focusing on cost controls while Medicare Advantage and Prescription ...

What Happened? A number of healthcare stocks fell in the afternoon session after several negative developments weighed on the ...

Centene (NYSE:CNC) underwent analysis by 11 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. In the table below, you'll find a summary of their recent ...

Centene's move comes after industry bellwether UnitedHealth pulled its guidance for the year and replaced its chief executive. It is likely to add to investors’ nervousness about the entire ...

Shares of Centene Corp. CNC slipped 1.84% to $53.40 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index SPX rising 0.96% to 6,025.17 ...